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Abstract
Background: Abnormal germline DNA methylation in males has been proposed as a possible mechanism compromising
spermatogenesis of some men currently diagnosed with idiopathic infertility. Previous studies have been focused on
imprinted genes with DNA methylation in poor quality human sperms. However, recent but limited data have revealed that
sperm methylation abnormalities may involve large numbers of genes or shown that genes that are not imprinted are also
affected.
Methodology/Principal Findings: Using the methylation-specific polymerase chain reaction and bisulfite sequencing
method, we examined methylation patterns of the promoter of methylenetetrahydrofolate reductase (MTHFR) gene
(NG_013351: 1538–1719) in sperm DNA obtained from 94 idiopathic infertile men and 54 normal fertile controls. Subjects
with idiopathic infertility were further divided into groups of normozoospermia and oligozoospermia. Overall, 45% (41/94)
of idiopathic infertile males had MTHFR hypermethylation (both hemimethylation and full methylation), compared with 15%
of fertile controls (P,0.05). Subjects with higher methylation level of MTHFR were more likely to have idiopathic male
infertility (P-value for trend =0.0007). Comparing the two groups of idiopathic infertile subjects with different sperm
concentrations, a higher methylation pattern was found in the group with oligozoospermia.
Conclusions: Hypermethylation of the promoter of MTHFR gene in sperms is associated with idiopathic male infertility. The
functional relevance of hypermathylation of MTHFR to male fertility warrants further investigation.
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Introduction
Infertility is a worldwide reproductive health problem that
affects approximately 15% of married couples. Half of these cases
are due to male factors [1], and about 60%–75% of male infertility
cases are idiopathic, since the molecular mechanisms underlying
the defects remain unknown [2]. In these patients, oligozoosper-
mia is frequently observed, and most infertile men resort to some
kind of assisted reproductive technique (ART). Even though this
method allows infertile male to father their own child without
knowing the cause of their infertility, it also carries the potential
risk of transmission of genetic or epigenetic aberrations to the
offsprings. Because the cause of alterations in sperm production is
unclear, we are interested in possible epigenetic causes.
Epigenetic alterations in DNA without concomitant changes in
underlying genetic codes are now known to occur frequently in
various human diseases [3–5]. It has been suggested that male
infertility might be linked to epigenetic alterations. Previous studies
have addressed this hypothesis and reported an association
between abnormal DNA methylation of imprinted genes and
disturbed spermatogenesis [6–8]. However, these studies interro-
gated for the most part imprinted loci with DNA methylation in
poor quality human sperms. Recent but limited data [9] have
revealed that sperm methylation abnormalities may involve large
numbers of genes or shown that genes that are not imprinted are
also affected. Although hints exist that spermatozoa from infertile
men can carry aberrant DNA methylation, there is little com-
pelling evidence to date to suggest that abnormal methylation
patterns of non-imprinted genes are associated with idiopathic
male infertility.
Methylenetetrahydrofolate reductase (MTHFR) is one of the
main regulatory enzymes involved in folate metabolism, DNA
synthesis and remethylation reactions. MTHFR catalyses the
reduction of methylenetetrahydrofolate (5, 10-methyl THF) to
PLoS ONE | www.plosone.org 1 November 2010 | Volume 5 | Issue 11 | e13884methyltetrahydrofolate (5-methyl THF). Thus, this enzyme has a
key role in balancing the pool of methyl groups between DNA
synthesis and DNA methylation. Recently, several association
studies have suggested that polymorphic variants in the MTHFR
gene may be associated with reduced sperm counts in humans,
leading to male infertility in some populations [10–13]. Addition-
ally, a very recent study showed that MTHFR promoter
hypermethylation was associated with non-obstructive azoosper-
mia in testicular biopsies of patients [14]. Furthering the
hypothesis that MTHFR plays an important role in spermatogen-
esis is the observation that MTHFR activity is about five times
higher in the adult mouse testes than that in other major organs
[15]. This finding, in conjunction with recent clinical evidence,
suggests an important role for MTHFR in spermatogenesis.
In this study, to test our hypothesis that hypermethylation of the
promoter region of MTHFR gene is associated with idiopathic
male infertility, we utilized carefully selected fertile controls to
evaluate the association between the MTHFR promoter hyper-
methylation and idiopathic male infertility.
Materials and Methods
Subject recruitment and sample collection
Study subjects were volunteers from the affiliated hospitals of
Nanjing Medical University between March 2006 and July 2009
(NJMU Infertile Study). The study was approved by the Institutional
Ethics Committee of Nanjing Medical University. All activities
involving human subjects were done under full compliance with
government policies and the Helsinki Declaration. Consecutive
eligible men (with wives not diagnosed as infertile) were recruited to
participate, 680 in total were asked. Of those approached, 82.5%
consented (561 participants, 507 cases and 54 controls). Written
informed consent was obtained from all study subjects. Infertile men
had an infertility history of at least 2 years with their spouses with
confirmed normal gynaecological assessment. The controls were
healthy men who had fathered at least one healthy child within one
year without assisted reproductive measures during the same period
as those of the cases recruited in the same hospital. A scheduled
interview was arranged for each subject to collect information,
including personal background, lifestyle factors, occupational and
environmental exposures, sexual and reproduction status, genetic
risk factors, medicalhistory and physicalactivity (e.g. exercise status).
Afterinterview,eachsubjectdonateda5-mlperipheralbloodsample
and a semen sample for genetic testing. These patients and healthy
donors were all ethnically Han Chinese from East China.
Semen analysis
Semen samples were obtained in private by masturbation into a
sterile widemouth and metal-free glass container after a recom-
mended at least 3-day sexual abstinence. After liquefaction at
37uC for 30 min, conventional semen analysis was conducted in
accordance with guidelines of the WHO Laboratory Manual for
the Examination of Human Semen [16], including semen volume,
sperm number per ejaculum, sperm concentration, motility, pro-
gression and motion parameters by using Micro-cell slide and
computer-aided semen analysis (CASA, WLJY 9000, Weili New
Century Science and Tech Dev.). Strict quality control measures
wereenforcedthroughoutthestudy.Eachsamplewasassessedtwice,
successively. A total of 507 infertile males underwent semen physical
examination, serum determination of estradiol (E2), testosterone (T),
prolactin (PRL), luteinizing hormone (LH), follicle-stimulating
hormone (FSH), karyotyping, and molecular tests for Y-chromo-
some microdeletions [17], and the results of these tests excluded 413
individuals: 67 azoospermia (9 obstructive azoospermic), 23 with
karyotype abnormality (nine of them with Klinefelter syndrome), 42
with Y-chromosome microdeletions, 37 with cryptorchidism and
244 secondary sterility cases. In the final analysis, we included 94
idiopathicinfertile males as thepatientgroupand 54fertile men with
normal semen parameters as the control group.
DNA isolation
The sperms were first washed with phosphate-buffered saline
twice and then washed with sperm wash buffer (SWB; 10 mM
Tris-HCl, 10 mM EDTA, 1 M NaCl, pH 7.0). Motile sperm cells
were purified away form lymphocyte contamination, immature
germ cells and epithelial cells using swim-up method [18]. A
microscopic examination of the sperm fractions was performed to
control the quality of cell preparations. Sperm was placed in SWB
and lysed at 55u? over night in the presence of 0.04 M
dithiothreotol (DTT), 0.5 mg/ml proteinase K and 0.9% SDS
[19]. DNA was extracted by using a standard method with
addition of 0.1 mM 2-mercaptoethanol [20], and DNA concen-
tration was determined by spectrophotometry.
Methylation-Specific PCR (MSP)
Genomic DNA (1 mg, or 500 ng when sperm DNA was not
enough) was treated with sodium bisulfite using the EpiTect
Bisulfite Kit (QIAGEN) according to the protocol recommended
by the manufacturer. Three microliters of the final eluant was used
for subsequent PCR amplification. The primers used were: meth-
ylated forward: 59-TAGATTTAGGTACGTGAAGTAGGGTA-
GAC-39, methylated reverse: 59-GAAAAACTAATAAAAAACC-
GACGAA-39, unmethylated forward: 59-TTTAGGTATGTGAA-
GTAGGGTAGATGT-39,u n m e t h y l a t e dr e v e r s e :5 9-CAAAAAAC-
TAATAAAAAACCAACAAA-39 [14]. For both PCR reactions, a
total of 100 ng of modified DNA was amplified in a 25 ml reaction
containing 0.5 mM each of forward and reverse primer, 200 mM
dNTPs, 16 PCR buffer and 1.25 U of Taq Hot Start DNA
Polymerase (Takara Bio, Tokyo, Japan) under the following
conditions: 5 min of denaturation at 95uC followed by 40 cycles of
40 s at 95uC, 40 s at 58uCf o rm e t h y l a t e dp r i m e r s( 5 9 uCf o r
unmethylated primers), 1 min at 72uCa n daf i n a le x t e n s i o nf o r
10 min at 72uC. The amplification products were separated on 2%
agarose gels, stained with ethidium bromide. Most samples were
subject to two independent bisulfite treatments and analyzed from
two independent PCR products. One control sperm DNA sample
was methylated using SssI methyltransferase (New England Biolabs)
according to the manufacturer’s protocol and used as methylated,
positive control for MSP reactions.
Bisulfite-Sequencing PCR (BSP)
To confirm that the MSP results accurately reflected the
methylation pattern of the promoter of MTHFR, we carried out
BSP assay. We examined a total of 18 CpG sites (CpGs) in a
299 bp fragment of the promoter of MTHFR (NG_013351: 1525–
1824; Figure 1). The primers were designed using Methprimer
software (http://www.urogene.org/methprimer/index1.html). The
primers used were: 59-TGAGAAAAGATTTTAGATTTAGGTA-
39 (forward), 59-AATCCAAAATAACAATAAAAAAAA-39 (reverse).
PCR included an initial incubation at 95uC for 10 minutes, followed
by 40 cycles of 95uC for 40 seconds, 51.9uC for 40 seconds, and 72uC
for 60 seconds, followed by one cycle of 72uC for 10 minutes. The
PCR products were purified and cloned into the pCR2.1 vector by
TA Cloning kit (Invitrogen, Carlsbad, CA, USA). To determine the
methylation status of the promoter of MTHFR gene, an average of 15
clones (each plate) were sequenced using M13 reverse primer and an
automated ABI Prism 3730xl Genetic Analyser (Applied Biosystems,
Foster city, CA, USA).
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Analysis of variance (ANOVA) was used to explore the
relationships between fertility status and potentially important
covariates, such as age, body mass index (BMI) and ejaculate
volume. Differences in sperm concentration and motility between
cases and controls were tested using Mann-Whitney test. The chi-
squared test was used to evaluate the differences in smoking status,
drinking status, duration of sexual abstinence, and the frequency of
hypermethylation of MTHFR between case and control groups.
To analyze the association between methylation patterns of
MTHFR and idiopathic male infertility with normal and abnormal
sperm concentrations, chi-square trend tests were performed.
Logistic regression analysis was performed to obtain the odds
ratios (ORs) for idiopathic male infertility and 95% confidence
intervals (95% CI) with adjustment for age, BMI, smoking status
and alcohol drinking, wherever it was appropriate. All statistical
analyses were carried out using Stata (Version 9.0, StataCorp, LP),
and P#0.05 were considered to be significant.
Results
We analyzed DNA methylation of the MTHFR gene in
spermatozoa from 94 idiopathic infertile males and 54 age-
matched fertile controls with normal endocrine status and semen
parameters. Demographic categories by fertility and sperm
concentration are described in Table 1.
Figure 1 shows a map of the CpG island (1477 bp) as well as the
PCR primers utilized for methylation analysis of the promoter of
MTHFR gene (NG_013351: 1538–1719). The percentage of
hemimethylation (both methylated and unmethylated alleles) of
MTHFR was 29% among idiopathic infertile patients and 13%
among fertile controls, while the prevalence of full methylation
(only the methylated allele) of MTHFR in idiopathic infertile males
and controls were 16% and 2%, respectively. Overall, 45% (41/94)
of idiopathic infertile males had hypermethylation (both hemi-
methylation and full methylation) in their sperms, compared with
15% of the fertile controls (Figure 2). A representative MSP analysis
Figure 1. The CpG island promoter region of the MTHFR gene. The CpG Island Searcher Program identified a CpG island within the MTHFR
gene promoter region, downstream of the transcriptional start site. Arrow represents the transcriptional start site, blue line depicts the CpG island
and the vertical bars represent a CpG site. Black lines and yellow lines represent the location of the MSP primers and BSP primers, respectively.
doi:10.1371/journal.pone.0013884.g001
Table 1. Characteristics of idiopathic infertile males and fertile controls.
Characteristic Controls (n=54)a Cases
Case 1 (n=30)
b Case 2 (n=64)
c Case all (n=94)
d
Age (years, mean 6 SD) 29.5263.72 29.6764.91 28.7564.34 29.0464.52
BMI (kg/m
2, mean 6 SD)
e 22.4262.54 21.0464.92 23.1162.93 22.4563.78
Smoking status [n (%)]
Yes 19 (35.2) 11 (36.7) 27 (42.2) 38 (40.4)
No 35 (64.8) 19 (63.3) 37 (57.8) 56 (59.6)
Alcohol drinking [n (%)]
Yes 13 (24.1) 4 (13.3) 10 (15.6) 14 (14.9)
No 41 (75.9) 26 (86.7) 54 (84.4) 80 (85.1)
Abstinence time [n (%)]
,4 36 (66.7) 14 (46.7) 33 (51.6) 47 (50.0)
4–7 17 (31.5) 11 (36.7) 23 (35.9) 34 (36.2)
.7 1 (1.9) 5 (16.7) * 8 (12.5) 13 (13.8)
Ejaculate volume (ml, mean 6 SD) 4.2461.04 3.1161.16* 3.1161.12* 3.1161.13*
Sperm concentration (10
6/ml)
f 41.25 (29.22–58.14) 61.65 (40–103.5)* 9.52 (3.86–14.33)* 14.08 (5.40–36.55)*
Sperm motility (%)
f 55.79 (44.00–67.40) 64.83 (43.48–79.21) 30.56 (16.30–41.62)* 36.03 (18.18–53.22)*
aControl: fertile men.
bCase 1: idiopathic infertile men with normozoospermia.
cCase 2: idiopathic infertile men with oligozoospermia.
dCase all: the sum of Case 1 and Case 2.
eBMI: body mass index.
fValues are given as median and interquartile range (IQR).
*P,0.05 when compared between case and control groups.
doi:10.1371/journal.pone.0013884.t001
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Significant differences were marked with *P,0.05 compared with the control.
doi:10.1371/journal.pone.0013884.g002
Figure 3. Methylation status of the promoter of MTHFR in genomic DNA prepared from ejaculated human sperm. (A) Representative
results of the MSP analysis of MTHFR. DNA obtained from the sperms was amplified with primers specific to the unmethylated (U) or the methylated
(M) of MTHFR after treatment with sodium bisulfite. (a) Fertile controls a1–a13 showed only the unmethylated allele. Others showed both methylated
and unmethylated alleles. (b) Idiopathic infertile males with normozoospermia (Case 1) b1–b9 showed only the unmethylated allele. Idiopathic
infertile males with normozoospermia b10–b14 showed both methylated and unmethylated alleles. Other showed only the methylated allele. (c)
Idiopathic infertile males with oligozoospermia (Case 2) c1–c8 showed only the unmethylated allele. Idiopathic infertile males with oligozoospermia
c9–c13 showed both methylated and unmethylated alleles. Others showed only the methylated allele. (B) Representative results of bisulfite-PCR
sequencing of MTHFR. Filled and open circles represent methylated and unmethylated CpGs, respectively. L: molecular weight markers; P: positive
control (universal methylated DNA).
doi:10.1371/journal.pone.0013884.g003
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with each methylation pattern were randomly selected and
confirmed by BSP assay. The results were 100% concordant
(Figure 3B). The frequency of hypermethylation of MTHFR was
significantly higherin idiopathicinfertilemen than in fertile controls
(P,0.05). These results indicate that the MTHFR promoter
methylation was frequently altered in idiopathic infertile patients.
For a more detailed analysis, the subjects was stratified by the
sperm concentration $20 and ,20 million spermatozoa/ml into
groups of 30 (Case 1) and 64 (Case 2) patients. MTHFR hemi-
methylation and full methylation was 31% and 14% respectively in
Case 2 group (Table 2), the frequencies were significantly higher
compared with the control group (13% and 2%, respectively;
P,0.05). Case 1 and Case 2 groups displayed hypermethylation of
40% and 45%, respectively (Figure 2), while Case 2 were
significantly different that of the controls (15%; P,0.05).
Adjusted ORs and 95% CIs for associations between idiopathic
male infertility and methylation patterns of MTHFR are presented
in Table 2. Compared with men with only unmethylated allele,
men with higher methylation levels were more likely to have
idiopathic infertility [ORs for increasing methylation levels =1.00
for unmethylated, 3.27 (95% CI, 1.21–8.87) for hemimethylated,
9.93 (95% CI, 1.10–90.31) for full methylated; P-value for trend
=0.0007]. When we divided the patients into Case 1 and Case 2
group according to a cut-off value of 20 mill./ml of the normal
sperm concentration, we found an increased risk for idiopathic
infertility among increasing methylation levels for both groups (P-
value for trend =0.0191 and 0.0006, respectively). Comparing the
two groups of idiopathic infertile subjects with different sperm
concentrations, a higher methylation pattern was found in the
group with oligozoospermia.
Discussion
There is a growing body of evidence highlighting the role that
aberrant DNA methylation plays in human diseases [2–5,21].
Several studies of European and Japanese cohorts provided
evidence that sperms from infertile men frequently had abnormal
levels of DNA methylation at imprinted loci [6–9]. Previous studies
have been focused on imprinted genes with DNA methylation in
poor quality human sperms [6–8] and conceptuses conceived using
ART (from infertile parents) [22]. However, recent but limited data
have revealed that sperm methylation abnormalities may involve
large numbers of genes or shown that genes that are not imprinted
arealso affected [9].Houshdaranand colleagues showedthat sperm
abnormalities may also be associated with a broad epigenetic defect
of increased DNA methylation at numerous sequences of diverse
types, such as non-imprinted genes and some repetitive elements
[9]. The results from these studies indicated that male infertility is
associated with aberrant methylation patterns of both imprinted
genes and non-imprinted genes.
Alterations in DNA methylation patterns impact several critical
cellular processes including gene expression, X-inactivation, car-
cinogenesis, aging and development [23–26]. It is well established
that hypomethylation is associated with transcriptional activation,
whereas hypermethylation is associated with repression of tran-
scription [23]. The product of the MTHFR gene is critical in
maintaining an adequate methionine pool and is believed to be
important in the process of DNA methylation [27]. MTHFR is
crucial to the folate pathway, and disruption of this enzyme com-
promises mouse development in several ways [28]. In male mice,
inactivation of MTHFR results in hyperhomocysteinemia and
infertility with abnormal testicular histology characterized by ab-
sence of germinal cells and spermatogenesis arrest [28]. Moreover,
Schwahn and coworkers postulated that accumulation of homocys-
teine and impaired transmethylation reactions may be the primary
factors in the MTHFR-related pathology [29]. Thus, these factors
may also underlie the spermatogenic failure in male infertility.
Our study has unveiled for the first time that the hypermethyla-
tion of MTHFR is a common event occurring in sperms of idio-
pathic infertile men, with 41 of 94 showing such epigenetic
aberration. This rate has almost tripled the prevalence found in the
fertile control group, which appears to be a frequent abnormality in
idiopathic infertile men, playing a significant role in causing
infertility. These results were in agreement with the findings of
Houshdaran and his colleagues [9], who demonstrated striking
associations between disruptive spermatogenesis and hypermethyla-
tionofseveralnon-imptinted genes.Additionally,ourresultswerein
accordance with a more recent study [14] that suggests that the
MTHFR promoter hypermethylation was associated with impaired
spermatogenesisininfetilemen.InthearticlebyKhazamipouretal,
hypermethylation of MTHFR was observed in testes of infertile
males, suggesting that epigenetic silencing of MTHFR could play a
role in male infertility.
Hypermethylation of the promoter of MTHFR gene is strongly
associated with idiopathic male infertility. Therefore, analysis of
Table 2. Adjusted ORs (95% CIs) for idiopathic male infertility by methylation patterns of MTHFR.
Methylation Control
a (n=54) Case
Case 1 (n=30)
b Case 2 (n=64)
c Case all (n=94)
d
n (%) n (%) OR (95% CI) n (%) OR (95% CI) n (%) OR (95% CI)
U
e 46 (85.2) 18 (60.0) 1.00 35 (54.7) 1.00 53 (56.2) 1.00
U/M
f 7 (13.0) 9 (30.0) 3.08 (0.96–9.92) 20 (31.3) 3.81 (1.41–10.31)* 29 (28.6) 3.27 (1.21–8.87)*
M
g 1 (1.9) 3 (10.0) 6.50 (0.57–73.81) 9 (14.1) 13.21 (1.57–111.39)* 12 (16.2) 10.42 (1.30–83.19)*
P-value for trend 0.0191 0.0006 0.0007
aControl: fertile men.
bCase 1: idiopathic infertile men with normozoospermia.
cCase 2: idiopathic infertile men with oligozoospermia.
dCase all: the sum of Case 1 and Case 2.
eU: unmethylation (only the unmethylated allele).
fU/M: hemimethylation (both methylated and unmethylated alleles).
gM: full methylation (only the methylated allele).
*P,0.05 compared with the unmethylation of MTHFR.
doi:10.1371/journal.pone.0013884.t002
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PLoS ONE | www.plosone.org 5 November 2010 | Volume 5 | Issue 11 | e13884promoter methylation in specific genes may provide biomarkers
valuable for the identification of individuals with an elevated risk
of male infertility. However, because our study is relatively small,
further large studies of different populations with additional
functional analysis of the hypermethylation are needed in order to
elucidate the role and the mechanisms of the MTHFR gene in
human spermatogenesis and the related pathology.
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